Navigation Links
EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124
Date:5/11/2010

WATERTOWN, Mass., May 11 /PRNewswire/ -- EnVivo Pharmaceuticals today announced the initiation and dosing of patients in a Phase IIb study of its EVP-6124 compound, a selective alpha-7 nicotinic agonist in patients with mild to moderate Alzheimer's disease.  The multi-center, dose ranging, placebo controlled, six-month study taking place in the U.S. and Europe is designed to determine the safety and efficacy of EVP-6124 in producing procognitive effects and improving the clinical condition of Alzheimer's disease patients.

"Patients with Alzheimer's disease have a number of symptomatic therapies available to them. However, the effects of the available medications are modest. Even if significant progress is made in slowing disease progression, more effective therapies that sustainably improve the cognition of the patients are clearly needed," said Kees Been, EnVivo president and CEO. "There is growing consensus that alpha-7 nicotinic agonists can potentially improve the cognitive function in Alzheimer's disease patients as evidenced by the number of large pharmaceutical companies advancing similar drugs through development. The potential upside for patients is considerable and we look forward to completing our Alzheimer's disease study by the middle of next year."

The Phase IIb study will enroll mild to moderate Alzheimer's disease patients who will be randomized to three separate doses of EVP-6124 or placebo over six months. Efficacy will primarily be determined by the ADAS-Cog scale, a commonly used and accepted measure of cognition in patients with Alzheimer's disease. Secondary assessments will include other cognitive and clinical measures. EVP-6124 also is being tested in patients with schizophrenia in a separate Phase IIb study that started in late 2009
'/>"/>

SOURCE EnVivo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer
2. EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimers Disease
3. EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimers Disease Transgenic Mouse Model With Gamma-Secretase Modulator
4. EnVivo Pharmaceuticals Announces Executive Appointment
5. Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
6. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-121 and Tarceva in Patients with Non-Small Cell Lung Cancer
7. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
8. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
9. Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
10. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
11. Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Cystic fibrosis (CF) is a genetic ... gastrointestinal organs. In particular, very thick mucus accumulates in ... difficult to clear, occludes the airways, and creates an ... frequently suffer from chronic biofilm infections, and ultimately succumb ... approach to treating the major challenges in the lungs ...
(Date:10/2/2014)... Mich. (PRWEB) October 02, 2014 MS ... with Hile Creative to refine its marketing approach. Backed ... MS Bioworks serves researchers in the biological sciences, including ... Bioworks has already seen substantial growth over the past ... with current customers, the company plans to launch a ...
(Date:10/2/2014)... (PRWEB) October 02, 2014 At a time ... Bel-Art Products has introduced a new kind of squeeze ... market is the Scienceware® Squeeze Rite™ Wash Bottle , ... tube position within the bottle reduces the waste of reagents, ... of those liquids. , “Easier to squeeze when compared to ...
(Date:10/2/2014)... CARLOS, Calif. and BRIDGEWATER, ... Corporation (NYSE: XON) , a leader in synthetic ... seventh largest generic drug manufacturer by volume in ... second Exclusive Channel Collaboration (ECC) for a target ... expression system, the goal of the collaboration is ...
Breaking Biology Technology:Synedgen to Present at North American Cystic Fibrosis Conference 2Synedgen to Present at North American Cystic Fibrosis Conference 3Hile Creative to Provide Copywriting and Graphic Design Services for MS Bioworks 2New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3
... Wis . - The Medical College of Wisconsin ... National Institute of Neurological Disorders and Stroke ... , ,The research, which will be led by principal ... examine the link between oxygen deficit and loss of ...
... Green Bay, Wis. - For six years, Steve Matheys served ... experience during that period - 1998 to 2004 - convinced him ... for bigger and better things in the executive suite. , ,Provided ... is. , ,Matheys, who now serves as executive vice president of ...
... Milwaukee, Wis . - He is fast becoming one of ... and if he has his way chief information officers and ... when they move to fill IT staff openings. , ... during the Wisconsin Entrepreneur's Conference in Milwaukee, is ...
Cached Biology Technology:Visions: Matheys says CIO role is good training for executive suite 2Visions: Matheys says CIO role is good training for executive suite 3Visions: Matheys says CIO role is good training for executive suite 4Jump starting technology education 2Jump starting technology education 3
(Date:9/30/2014)... farm runoff in Hawaii is causing tumors in endangered ... study, published Tuesday in the peer-reviewed open-access journal ... up in algae that the turtles eat, promoting the ... internal organs. , Scientists at Duke University, the University ... (NOAA) conducted the study to better understand the causes ...
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... pregnanteven with IVF? Here,s some hope: A new research ... The FASEB Journal , explains how scientists developed ... PAWP, which induced embryo development in human and mouse ... by the sperm cell during fertilization. , "We believe ... paradigm shift in our understanding of human fertilization by ...
Breaking Biology News(10 mins):Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Cancer therapy: Driving cancer cells to suicide 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... dinner fat intake seem to influence negatively the sleep pattern ... be presented on Tuesday at SLEEP 2008, the 22nd Annual ... study, authored by Cibele Crispim, of the Federal University of ... 20-45 years of age, whose food intake was analyzed by ...
... forensic scientists at the University of Copenhagen has studied human ... to the iron age, and discovered a man who appears ... beings were as genetically diverse 2000 years ago as they ... than was previously thought. The findings also suggest that people ...
... A new book, Grounds for Knowledge , ... modern buildings and the striking landscape that surrounds them. ... L. Watson, who, together with her husband James D. Watson ... picturesque grounds of CSHL for almost four decades. The ...
Cached Biology News:Fat intake negatively influences the sleep pattern in healthy adults 2New research refutes myth of pure Scandinavian race 2New research refutes myth of pure Scandinavian race 3
Request Info...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... DNAzol Reagents are complete ready-to-use reagents for ... Reagent is specifically formulated for the isolation ... Reagent is specifically formulated for the isolation ... isolated with DNAzol Reagents can be used ...
Biology Products: